In vitro, in vivo, and postmortem studies have reported that LRP8 levels in AD are significantly reduced compared to healthy controls (Hinrich et al., 2016; Mata Balaguer et al., 2018). The gene discussed is LRP8; the disease is Alzheimer disease.